Mulmit

CRESCENT BIOPHARMA, INC.CRESCENT BIOPHARMA, INC.

CBIO Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3110,844,000-152,632,000153,942

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-16Fairmount Funds Management LLC853,450
2026-07-16Fairmount Funds Management LLC525,897
2026-06-22Lynch RyanSee Remarks465
2026-06-22Pinkas JanChief Scientific Officer1,288
2026-06-22Scalzo Richard WilliamChief Financial Officer1,112
2026-06-22Bispham Barbara HarlinSee Remarks1,218
2026-06-22Im Ellie EunkyungChief Medical Officer1,219
2026-06-22McNeill JonathanPresident and COO20,549
2026-06-22Brumm Joshua TChief Executive Officer42,305
2026-06-02Violin Jonathan11,050
2026-06-02Lubner David Charles11,050
2026-06-02Balcom Alexandra11,050

8-K events

FiledItems
2026-07-30Results of operations · Financial statements and exhibits
2026-07-15Other events · Financial statements and exhibits
2026-07-14Results of operations
2026-06-03Submission of matters to a vote
2026-04-29Results of operations · Financial statements and exhibits
2026-02-26Results of operations · Financial statements and exhibits
2025-12-04Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Other events · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.